US Patent 10947295 Heterodimers of soluble interferon receptors and uses thereof
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+195 characters)
Article
Patent abstract
The present disclosure provides soluble interferon receptors. The methods of the disclosure can be used to treat or prevent a condition associated with an abnormal immune response.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
109472950
Date of Patent
March 16, 2021
0Patent Application Number
161096720
Date Filed
August 22, 2018
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
109472950
Date of Patent
March 16, 2021
0Patent Application Number
161096720
Date Filed
August 22, 2018
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10947295 Heterodimers of soluble interferon receptors and uses thereof
Infobox
Is a
Patent jurisdiction
Patent number
10947295
Date of patent
March 16, 2021
Patent application number
16109672
Date Filed
August 22, 2018
Patent primary examiner
Find more entities like US Patent 10947295 Heterodimers of soluble interferon receptors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.